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HYPERGLYCEMIA SELECTIVELY INCREASES THE
EXPRESSION OF CYCLOXYGENASE-2 IN HUMAN
AORTIC ENDOTHELIAL CELLS
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Volpe°. Istituto Neurologico Mediterraneo “Neuromed” Pozzilli
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The conversion of arachidonic acid to vasoactive prosta-
noids including prostacyclin, prostaglandins and trombox-
anes is mediated by cycloxygenase (COX). Two isoforms of
enzyme have been shown: a constitutive (COX-1) and an
inducible form (COX-2). Products of the arachidonic acid
metabolism may be involved in the impairment of endothe-
lium-dependent vasodilatation observed both in experimen-
tal models and in patients with diabetes mellitus. To deter-
mine the effect of hyperglycemia on COX-1 and COX-2
expression, human aortic endothelial cells (HAEC) were
exposed to normal (5.5mM) and high (22.2mM) concentra-
tions of glucose for 5 days. Cells were also treated with
mannitol (22.2 mM) to rule out an effect due to osmolality
changes. COX-1 and COX-2 mRNA and protein expressions
were analyzed by Southern and Western blotting, respec-
tively. Treatment with high glucose was associated with a
two-fold increase of both COX-2 mRNA (P,0.05) and pro-
tein levels (P,0.05), whereas no changes were observed for
COX-1. Moreover high concentration of mannitol did not
exert any significant effect. The present study demonstrates
that both isoforms of COX are normally expressed in HAEC,
but only COX-2 was stimulated after exposure to high glucose.
The results of the present study may provide molecular basis to
understand hyperglycemia-induced endothelial dysfunction.
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ENDOTHELIUM DEPENDENT AND INDEPENDENT
VASODILATION IN SALT-SENSITIVE AND SALT-
RESISTANT ESSENTIAL HYPERTENSION
E. Bragulat*, A. de la Sierra*, M.T. Antonio, N. Agirreolea,
M.T. Aguilera, A. Urbano-Ma´rquez, A. Coca*. Hypertension
Unit. Hospital Clinic, Barcelona, Spain
The aim of the study was to evaluate endothelial function in
essential hypertensives (EH) classified according to the pres-
ence of salt-sensitivity (SS) or salt-resistance (SR). Thirty-
seven never treated EH patients without evidence of target
organ damage were studied. Salt-sensitive hypertension was
defined as a significant rise (p,0.05) in 24-hour mean BP,
measured by means of ABPM, from a 7-day period of low-
salt intake (50 mmol/day) to a 7-day period of high-salt
intake (250 mmol/day). At the end of the high-salt period,
endothelial function was determined by means of the fore-
arm vascular response (by strain-gauge plethysmography)
to intrabrachial infusion of increasing doses of acetylcholine,
an endothelium-dependent vasodilator, or sodium nitro-
prusside, an endothelium-independent vasodilator, with
and without the presence of the NO synthase inhibitor L-
NMMA. When compared to SR hypertensives (n516), SS
patients (n521) exhibited a significant decreased endotheli-
um-dependent vasodilation. The maximal acetylcholine in-
duced vasodilation was (mean6sem) 358636% in SS hyper-
tensives and 518639% in SR patients (p50.005). The
addition of L-NMMA significantly reduced acetylcholine
induced vasodilation in SR patients (from 518% to 318%),
but not in SS patients (from 358% to 292%). The endotheli-
um-independent vasodilation did not differ between groups
(maximal response to sodium nitroprusside infusion:
411632% in SS vs. 378630 in SR; p50.464), and it was
unmodified with the addition of L-NMMA. In conclusion,
salt sensitivity of essential hypertension is associated with a
decrease in acetylcholine-induced vasodilation, indicating
an impairment in endothelial L-arginine NO pathway.
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IN PRIMARY ALDOSTERONISM HYPERTENSIVE
PATIENTS ENDOTHELIAL DYSFUNCTION IS
CAUSED BY AN IMPAIRMENT IN NO AVAILABILITY
I. Sudano, A. Virdis, L. Ghiadoni, H. Cardinal, A. Moretti,
G.P. Bernini, S. Taddei*, A. Salvetti*. Department of Internal
Medicine, University of Pisa, Italy
Hypertensive patients with primary aldosteronism (PA) are
characterized by an impaired endothelium(END)-depen-
dent vasodilation (VD). Aim of the study was to evaluate
whether this alteration is secondary to high blood pressure
levels and caused by a defect in the L-arginine-NO pathway.
In n510 normotensive subjects (N, 49.5616.8 years;
121.463.6/80.463.1 mmHg) and n5 7 PA (51.466.5 years;
166.8613/108.468.6 mmHg; plasma potassium (K pl)
2.960.3) we studied the forearm blood flow changes (FBF:
strain-gauge venous plethysmography) induced by intra-
arterial acetylcholine (ACH: 0.15, 0.45, 1.5, 4.5, 15 mg/100
ml/min), an END-dependent agonist, or sodium nitroprus-
side (SNP, 1, 2, 4 mg/100 ml/min), an END-independent
vasodilator. ACH was repeated during L-NMMA (100 mg/
100 ml/min), an NO-synthase inhibitor. VD to ACH was
significantly (*p,0.05) reduced in PA (FBF % increase above
baseline: 13615, 34620, 98634, 198644*, 319647*) as com-
pared to N (FBF %: 2561, 5865, 155.6632, 369648, 547653),
while response to SNP was similar in the two groups (FBF
%: PA: 88620, 199632, 323658; N: 109614, 219638, 361677,
N.S.). L-NMMA blunted (*p,0.05) VD to ACH in N (FBF%:
9610, 38618, 96627*, 154634*, 237645*), while was ineffec-
tive in PA (FBF %: 5615, 35619, 114633, 201645, 310647).
In PA the study was repeated within 3 months after surgical
removal of adrenal adenoma, when blood pressure
(119.864.4/83.163.4 mmHg) and K pl (3.960.4) were nor-
malized. VD to ACH significantly (*p,0.01) increased (FBF
% 19617, 55625, 148639, 327641*, 491635*) and was no
longer different from N. L-NMMA significantly (*p,0.05)
blunted VD to ACH (FBF %: 16612, 2469, 72618*, 131638*,
244658*). VD to SNP was unchanged (FBF%: 87617,
190639, 349656). In conclusions these data shown that en-
dothelial dysfunction in PA is caused by an impairment of
NO availability, an alteration which can be reversed by
removal of adrenal adenoma and BP normalization.
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